MENU
WDNA
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

WDNA stock forecast, quote, news & analysis

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”)... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for WDNA with price predictions
Nov 09, 2026

WDNA's Stochastic Oscillator stays in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on WDNA as a result. In 61 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

WDNA moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for WDNA crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +5.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where WDNA advanced for three days, in 213 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 180 of 239 cases where WDNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for WDNA turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 35 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WDNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

WDNA broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Moderna (NASDAQ:MRNA), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), ZOETIS (NYSE:ZTS), Illumina (NASDAQ:ILMN).

Industry description

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Market Cap

The average market capitalization across the WisdomTree BioRevolution Fund (WDNA) ETF is 54.55B. The market cap for tickers in the group ranges from 261.81M to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is RCKT at 261.81M.

High and low price notable news

The average weekly price growth across all stocks in the WisdomTree BioRevolution Fund (WDNA) ETF was 1%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 33%. XNCR experienced the highest price growth at 30%, while VCYT experienced the biggest fall at -47%.

Volume

The average weekly volume growth across all stocks in the WisdomTree BioRevolution Fund (WDNA) ETF was -3%. For the same stocks of the ETF, the average monthly volume growth was 11% and the average quarterly volume growth was -8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 48
Price Growth Rating: 46
SMR Rating: 80
Profit Risk Rating: 79
Seasonality Score: 19 (-100 ... +100)
WDNA's Stochastic Oscillator stays in oversold zone for 1 day